Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Neovasc logo

About Neovasc Stock (NASDAQ:NVCN)

Advanced Chart

Key Stats

Today's Range
$30.03
$30.03
50-Day Range
$29.03
$30.03
52-Week Range
$4.59
$30.07
Volume
1 shs
Average Volume
56,993 shs
Market Capitalization
$82.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Closing Bell: Neovasc Inc down on Tuesday (NVCN)
Closing Bell: Neovasc Inc up on Monday (NVCN)
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
Neovasc Announces German Reimbursement Renewal
See More Headlines

NVCN Stock Analysis - Frequently Asked Questions

Neovasc Inc. (NASDAQ:NVCN) posted its earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) EPS for the quarter, missing the consensus estimate of ($2.25) by $0.50. The medical equipment provider had revenue of $0.70 million for the quarter, compared to the consensus estimate of $1.20 million. Neovasc had a negative trailing twelve-month return on equity of 127.25% and a negative net margin of 1,082.92%.

Shares of Neovasc reverse split on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/09/2021
Today
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVCN
Employees
49
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-41,200,000.00
Net Margins
-1,082.92%
Pretax Margin
-1,082.26%

Debt

Sales & Book Value

Annual Sales
$3.81 million
Price / Cash Flow
N/A
Book Value
$5.77 per share
Price / Book
5.20

Miscellaneous

Free Float
N/A
Market Cap
$82.28 million
Optionable
Not Optionable
Beta
1.70

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:NVCN) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners